NICE climbdown over anti-flu drug Relenza

Posted on September 1st, by editor in Caring Times. No Comments

Elderly people in care homes are among those who will benefit from a change of heart by the National Institute of Clinical Excellence (NICE) with regard to the anti-flu drug Relenza. NICE reversed a decision last year not to make the drug available on the NHS, and now says that people over 65, those with respiratory disease, those with lowered resistance to infection (for example, those with diabetes) should have access to the drug when flu is “circulating in the community”. Official guidelines suggest that this occurs when 50 to 400 cases of flue occur per 100,000 GP consultations. Vaccination remains the mainstay of preventing flu in all those at risk, but Relenza will, in some patients, reduce the chances of developing flu, and may reduce the length and severity of the illness.

Comments are closed.

Latest blog posts

Time for a ten dollar answer

By Caring Times editor GEOFF HODGSON

Ernest Hemingway was known for his minimalist style and he used to pooh-pooh what he called “ten-dollar” words. Not to...

Lacking capacity

By guest blogger JEF SMITH

A friend of mine diagnosed with cancer – now, happily, treated – was asked how he could possibly have missed the...

Care homes – understated examples of tasteful design

By Caring Times editor GEOFF HODGSON

Dozens of recently-built care homes are material proof that it is perfectly possible to design aesthetically pleasing buildings and put...